<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">66376</article-id><article-id pub-id-type="doi">10.7554/eLife.66376</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Sensitizing <italic>Staphylococcus aureus</italic> to antibacterial agents by decoding and blocking the lipid flippase MprF</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-221315"><name><surname>Slavetinsky</surname><given-names>Christoph Josef</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5576-5906</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-222490"><name><surname>Hauser</surname><given-names>Janna Nadine</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-222491"><name><surname>Gekeler</surname><given-names>Cordula</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-222492"><name><surname>Slavetinsky</surname><given-names>Jessica</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-222493"><name><surname>Geyer</surname><given-names>André</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-222494"><name><surname>Kraus</surname><given-names>Alexandra</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-222495"><name><surname>Heilingbrunner</surname><given-names>Doris</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-114456"><name><surname>Wagner</surname><given-names>Samuel</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1808-3556</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-222496"><name><surname>Tesar</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-222497"><name><surname>Krismer</surname><given-names>Bernhard</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-222498"><name><surname>Kuhn</surname><given-names>Sebastian</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-117014"><name><surname>Ernst</surname><given-names>Christoph M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5575-1325</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-32303"><name><surname>Peschel</surname><given-names>Andreas</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf5"/></contrib><aff id="aff1"><institution content-type="dept">Pediatric Gastroenterology and Hepatology</institution>, <institution>Eberhard Karls University Tübingen</institution>, <addr-line><named-content content-type="city">Tübingen</named-content></addr-line>, <country>Germany</country></aff><aff id="aff2"><institution content-type="dept">Department of Infection Biology</institution>, <institution>Eberhard Karls University Tübingen</institution>, <addr-line><named-content content-type="city">Tübingen</named-content></addr-line>, <country>Germany</country></aff><aff id="aff3"><institution>MorphoSys AG</institution>, <addr-line><named-content content-type="city">Planegg</named-content></addr-line>, <country>Germany</country></aff><aff id="aff4"><institution content-type="dept">Cluster of Excellence 'Controlling Microbes to Fight Infections'</institution>, <institution>University of Tübingen</institution>, <addr-line><named-content content-type="city">Tübingen</named-content></addr-line>, <country>Germany</country></aff><aff id="aff5"><institution content-type="dept">Department of Molecular Biology and Center for Computational and Integrative Biology</institution>, <institution>Broad Institute</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Department of Infection Biology</institution>, <institution>Eberhard Karls University Tübingen</institution>, <addr-line><named-content content-type="city">Tuebingen</named-content></addr-line>, <country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-150133"><name><surname>Zambrano</surname><given-names>María Mercedes</given-names></name><role>Reviewing editor</role><aff><institution>CorpoGen</institution>, <country>Colombia</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>christoph.slavetinsky@med.uni-tuebingen.de</email> (CS);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>cmernst@broadinstitute.org</email> (CE);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>19</day><month>01</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e66376</elocation-id><history><date date-type="received"><day>08</day><month>01</month><year>2021</year></date><date date-type="accepted"><day>18</day><month>01</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Slavetinsky et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Slavetinsky et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-66376-v1.pdf"/><abstract><p>The pandemic of antibiotic resistance represents a major human health threat demanding new antimicrobial strategies. MprF is the synthase and flippase of the phospholipid lysyl-phosphatidylglycerol that increases virulence and resistance of methicillin-resistant <italic>Staphylococcus aureus </italic>(MRSA) and other pathogens to cationic host defense peptides and antibiotics. With the aim to design MprF inhibitors that could sensitize MRSA to antimicrobial agents and support the clearance of staphylococcal infections with minimal selection pressure, we developed MprF-targeting monoclonal antibodies, which bound and blocked the MprF flippase subunit. Antibody M-C7.1 targeted a specific loop in the flippase domain that proved to be exposed at both sides of the bacterial membrane, thereby enhancing the mechanistic understanding of bacterial lipid translocation. M-C7.1 rendered MRSA susceptible to host antimicrobial peptides and antibiotics such as daptomycin, and it impaired MRSA survival in human phagocytes. Thus, MprF inhibitors are recommended for new anti-virulence approaches against MRSA and other bacterial pathogens.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>EXC-2124/1-09.001_0</award-id><principal-award-recipient><name><surname>Slavetinsky</surname><given-names>Christoph Josef</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>EXC-2124/1-09.010_0</award-id><principal-award-recipient><name><surname>Slavetinsky</surname><given-names>Christoph Josef</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009139</institution-id><institution>Deutsches Zentrum für Infektionsforschung</institution></institution-wrap></funding-source><award-id>TTU 08.806</award-id><principal-award-recipient><name><surname>Slavetinsky</surname><given-names>Christoph Josef</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009139</institution-id><institution>Deutsches Zentrum für Infektionsforschung</institution></institution-wrap></funding-source><award-id>TTU 08.806</award-id><principal-award-recipient><name><surname>Peschel</surname><given-names>Andreas</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>SFB 766/1-3,TP A08</award-id><principal-award-recipient><name><surname>Peschel</surname><given-names>Andreas</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Alexandra Kraus, Antibodies disclosed in the manuscript are part of patent Anti-staphylococcal antibodies&quot; (US9873733B2 / EP2935324B1).</p></fn><fn fn-type="conflict" id="conf3"><p>Michael Tesar, Antibodies disclosed in the manuscript are part of patent Anti-staphylococcal antibodies&quot; (US9873733B2 / EP2935324B1).</p></fn><fn fn-type="conflict" id="conf4"><p>Christoph M Ernst, Antibodies disclosed in the manuscript are part of patent Anti-staphylococcal antibodies&quot; (US9873733B2 / EP2935324B1).</p></fn><fn fn-type="conflict" id="conf5"><p>Andreas Peschel, Antibodies disclosed in the manuscript are part of patent Anti-staphylococcal antibodies&quot; (US9873733B2 / EP2935324B1).</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><supplementary-material><ext-link xlink:href="elife-66376-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>